Abrocitinib can help achieve minimal disease activity in patients with atopic dermatitis irrespective of previous exposure to ...

FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...

Diagnosis and management of atopic dermatitis, a type of eczema, are complicated by skin temperature fluctuations, unclear ...

LEO Pharma announces key results of Phase 2 TRAPEDS-1 trial evaluating pharmacokinetics and safety of tralokinumab ...

Add Yahoo as a preferred source to see more of our stories on Google. Considered in the past to be primarily a children's condition, atopic dermatitis can affect people of all ages If you’re over 60 ...

Turn Therapeutics (NASDAQ:TTRX) outlined the final stage two design and data-driven expansion of its GX-03 phase II program ...

Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies ...

Arcutis Biotherapeutics said the U.S. Food and Drug Administration has accepted its application seeking expanded approval of its Zoryve topical treatment for infants with atopic dermatitis, the most ...

Flaky scalp, itchiness and painful patches can all be signs of scalp dermatitis, an inflammation of the scalp that can have as many causes as it does symptoms. In most cases, it's not a serious ...

What is contact dermatitis? Contact dermatitis is a reaction that occurs when something touches your skin and triggers a rash. The rash may appear right away or it could take some time to develop.

Watch rot' is trending online, but experts warn smartwatch overuse may cause contact dermatitis. Learn the symptoms, causes ...

Dupilumab demonstrated robust efficacy, durable benefits, and a favorable safety profile in children with moderate-to-severe ...